Medicine and Dentistry
Pediatrics
100%
Diseases
95%
Neoplasm
89%
Papillomatosis
84%
Tongue
74%
Ploidy
63%
Disease Course
58%
Metastatic Carcinoma
54%
Subglottic Stenosis
45%
Recurrent Disease
44%
Squamous Cell Carcinoma
42%
Cell Proliferation
37%
Neck
37%
Papilloma
35%
Surgical Anastomosis
35%
Growth Factor
32%
Radiation Therapy
31%
Biopsy Technique
31%
Prognostic Factor
30%
Bronchoscopy
29%
Carcinoma
29%
Papillary Endothelial Hyperplasia
28%
Angiosarcoma
28%
Scoring System
28%
Foreign Body Aspiration
28%
Papillary Carcinoma
28%
Vocal Folds
26%
Prospective Study
23%
Stenting
23%
Cancer
23%
Reflux
22%
Pediatrics Patient
21%
Laryngoscopy
21%
Surgical Technique
21%
Granulation Tissue
21%
Neck Dissection
21%
S Phase
21%
Aneuploidy
20%
Intubation
20%
Papillary Thyroid Cancer
18%
Blood Clotting Factor 8
18%
Gastroesophageal Reflux
18%
Tracheoesophageal Fistula
18%
Cricoid Cartilage
17%
Epidermal Growth Factor Receptor
17%
Melanoma
17%
Surgical Margin
17%
Vascularity
16%
Microvessel
16%
Extracellular Matrix
16%
Keyphrases
DNA Ploidy
67%
Recurrent Respiratory Papillomatosis
63%
Clinical Course
59%
Thyroid Gland
56%
Juvenile-onset Recurrent Respiratory Papillomatosis
56%
Tumor
52%
Subglottic Stenosis
45%
Pediatric
44%
Papillary Thyroid Carcinoma
42%
Partial Cricotracheal Resection
42%
Laryngotracheal Reconstruction
42%
Pediatric Population
41%
Cell Proliferation
40%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
37%
DNA Content
34%
Benign Lesion
33%
Medical Center
31%
Prognostic Factors
31%
Papilloma
30%
Ki-67 Expression
28%
Tongue
28%
Angiosarcoma
28%
Nuclear DNA Content
28%
Tongue Cancer
28%
Scoring System
28%
Foreign Body Aspiration
28%
Primary Anastomosis
28%
Aggressive Disease
26%
Pediatric Patients
25%
Carcinoma
25%
Flap
24%
Stent
24%
Head-and-neck
24%
Biopsy Specimen
24%
Decannulation
23%
Respiratory Papillomatosis
23%
Growth Factors
23%
Prognosis Prediction
23%
Phase Fraction
23%
Ki-67
23%
Site of Disease
22%
Airway
22%
Reflux
22%
Israel
21%
Malignancy
21%
Radiotherapy
21%
Granulation Tissue
21%
Metastasis
20%
Excision
19%
Proliferative Markers
18%